Legato Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Sell |
21,777
-345
| -2% | -$3.09K | 0.02% | 521 |
|
|
2025
Q1 | $166K | Sell |
22,122
-1,471
| -6% | -$11K | 0.02% | 522 |
|
|
2024
Q4 | $177K | Hold |
23,593
| – | – | 0.02% | 528 |
|
|
2024
Q3 | $179K | Hold |
23,593
| – | – | 0.02% | 526 |
|
|
2024
Q2 | $146K | Buy |
23,593
+368
| +2% | +$2.27K | 0.02% | 529 |
|
|
2024
Q1 | $118K | Hold |
23,225
| – | – | 0.01% | 543 |
|
|
2023
Q4 | $139K | Hold |
23,225
| – | – | 0.02% | 541 |
|
|
2023
Q3 | $164K | Buy |
+23,225
| New | +$164K | 0.02% | 518 |
|